Cachectic body composition and inflammatory markers portend a poor prognosis in patients with locally advanced pancreatic cancer treated with chemoradiation
Background: Patients with pancreatic cancer often develop cancer cachexia, a complex multifactorial syndrome with weight loss, muscle wasting and adipose tissue depletion with systemic inflammation causing physical impairment. In patients with locally advanced pancreatic cancer (LAPC) neoadjuvant tr...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
26 October 2019
|
| In: |
Cancers
Year: 2019, Volume: 11, Issue: 11 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers11111655 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers11111655 Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/11/11/1655 
|
| Author Notes: | Patrick Naumann, Jonathan Eberlein, Benjamin Farnia, Jakob Liermann, Thilo Hackert, Jürgen Debus and Stephanie E. Combs |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1686331487 | ||
| 003 | DE-627 | ||
| 005 | 20210819114311.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191223s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers11111655 |2 doi | |
| 035 | |a (DE-627)1686331487 | ||
| 035 | |a (DE-599)KXP1686331487 | ||
| 035 | |a (OCoLC)1264283590 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Naumann, Patrick |d 1981- |e VerfasserIn |0 (DE-588)1021553891 |0 (DE-627)715821318 |0 (DE-576)36276266X |4 aut | |
| 245 | 1 | 0 | |a Cachectic body composition and inflammatory markers portend a poor prognosis in patients with locally advanced pancreatic cancer treated with chemoradiation |c Patrick Naumann, Jonathan Eberlein, Benjamin Farnia, Jakob Liermann, Thilo Hackert, Jürgen Debus and Stephanie E. Combs |
| 264 | 1 | |c 26 October 2019 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.12.2019 | ||
| 520 | |a Background: Patients with pancreatic cancer often develop cancer cachexia, a complex multifactorial syndrome with weight loss, muscle wasting and adipose tissue depletion with systemic inflammation causing physical impairment. In patients with locally advanced pancreatic cancer (LAPC) neoadjuvant treatment is routinely performed to allow a subsequent resection. Herein, we assess body composition and laboratory markers for cancer cachexia both before and after neoadjuvant chemoradiation (CRT). Methods: Subcutaneous fat (SCF), visceral fat (VF), skeletal muscle (SM), weight and laboratory parameters were determined longitudinally in 141 LAPC patients treated with neoadjuvant CRT. Changes during CRT were statistically analyzed and correlated with outcome and Kaplan–Meier curves were plotted. Different prognostic factors linked to cachexia were assessed by uni- and multivariable cox proportional hazards models. Results: There was a significant decrease in weight as well as SCF, VF and SM during CRT. The laboratory parameter C-reactive protein (CRP) increased significantly, whereas there was a significant decrease in leukocyte count, hemoglobin, albumin and cholinesterase as well as in the tumor marker CA 19.9. Cachectic weight loss, sarcopenia, reductions in body compartments SCF, VF and SM, and changes in laboratory markers as well as resection affected survival in univariable analysis. In multivariable analysis, weight loss >5% (HR 2.8), reduction in SM >5% (HR 5.5), an increase in CRP (HR 2.2) or CA 19.9 (HR 1.9), and resection (HR 0.4) remained independently associated with survival, whereas classical cachexia and sarcopenia did not. Interestingly, the subgroup of patients with cachectic weight loss >5% or SM reduction >5% during CRT did not benefit from resection (median survival 12 vs. 27 months). Conclusions: Persistent weight loss and muscle depletion during CRT as well as systemic inflammation after CRT impacted survival more than cachexia or sarcopenia according classical definitions. | ||
| 650 | 4 | |a adipose tissue | |
| 650 | 4 | |a body composition | |
| 650 | 4 | |a cachexia | |
| 650 | 4 | |a chemoradiation | |
| 650 | 4 | |a locally advanced pancreatic cancer | |
| 650 | 4 | |a muscle wasting | |
| 650 | 4 | |a sarcopenia | |
| 650 | 4 | |a skeletal muscle index | |
| 650 | 4 | |a weight loss | |
| 700 | 1 | |a Eberlein, Jonathan |d 1989- |e VerfasserIn |0 (DE-588)1160900639 |0 (DE-627)1024294498 |0 (DE-576)506231097 |4 aut | |
| 700 | 1 | |a Farnia, Benjamin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Liermann, Jakob |d 1989- |e VerfasserIn |0 (DE-588)1147779287 |0 (DE-627)1007181842 |0 (DE-576)496034170 |4 aut | |
| 700 | 1 | |a Hackert, Thilo |d 1971- |e VerfasserIn |0 (DE-588)122158512 |0 (DE-627)70579346X |0 (DE-576)182659208 |4 aut | |
| 700 | 1 | |a Debus, Jürgen |d 1964- |e VerfasserIn |0 (DE-588)1022671421 |0 (DE-627)717025780 |0 (DE-576)365774944 |4 aut | |
| 700 | 1 | |a Combs, Stephanie E. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 11(2019,11) Artikel-Nummer 1655, 17 Seiten |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Cachectic body composition and inflammatory markers portend a poor prognosis in patients with locally advanced pancreatic cancer treated with chemoradiation |
| 773 | 1 | 8 | |g volume:11 |g year:2019 |g number:11 |g extent:14 |a Cachectic body composition and inflammatory markers portend a poor prognosis in patients with locally advanced pancreatic cancer treated with chemoradiation |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers11111655 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/11/11/1655 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20191223 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1022671421 |a Debus, Jürgen |m 1022671421:Debus, Jürgen |d 910000 |d 911400 |e 910000PD1022671421 |e 911400PD1022671421 |k 0/910000/ |k 1/910000/911400/ |p 6 | ||
| 998 | |g 122158512 |a Hackert, Thilo |m 122158512:Hackert, Thilo |d 910000 |d 910200 |e 910000PH122158512 |e 910200PH122158512 |k 0/910000/ |k 1/910000/910200/ |p 5 | ||
| 998 | |g 1147779287 |a Liermann, Jakob |m 1147779287:Liermann, Jakob |d 910000 |d 911400 |e 910000PL1147779287 |e 911400PL1147779287 |k 0/910000/ |k 1/910000/911400/ |p 4 | ||
| 998 | |g 1160900639 |a Eberlein, Jonathan |m 1160900639:Eberlein, Jonathan |d 910000 |d 911400 |e 910000PE1160900639 |e 911400PE1160900639 |k 0/910000/ |k 1/910000/911400/ |p 2 | ||
| 998 | |g 1021553891 |a Naumann, Patrick |m 1021553891:Naumann, Patrick |d 910000 |d 911400 |e 910000PN1021553891 |e 911400PN1021553891 |k 0/910000/ |k 1/910000/911400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1686331487 |e 3570317544 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Cachectic body composition and inflammatory markers portend a poor prognosis in patients with locally advanced pancreatic cancer treated with chemoradiation","title":"Cachectic body composition and inflammatory markers portend a poor prognosis in patients with locally advanced pancreatic cancer treated with chemoradiation"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Gesehen am 23.12.2019"],"origin":[{"dateIssuedDisp":"26 October 2019","dateIssuedKey":"2019"}],"person":[{"role":"aut","given":"Patrick","family":"Naumann","display":"Naumann, Patrick"},{"display":"Eberlein, Jonathan","family":"Eberlein","role":"aut","given":"Jonathan"},{"family":"Farnia","given":"Benjamin","role":"aut","display":"Farnia, Benjamin"},{"display":"Liermann, Jakob","given":"Jakob","role":"aut","family":"Liermann"},{"display":"Hackert, Thilo","given":"Thilo","role":"aut","family":"Hackert"},{"display":"Debus, Jürgen","role":"aut","given":"Jürgen","family":"Debus"},{"family":"Combs","given":"Stephanie E.","role":"aut","display":"Combs, Stephanie E."}],"relHost":[{"disp":"Cachectic body composition and inflammatory markers portend a poor prognosis in patients with locally advanced pancreatic cancer treated with chemoradiationCancers","recId":"614095670","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Cancers","title_sort":"Cancers"}],"note":["Gesehen am 27.05.2020"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"origin":[{"publisher":"MDPI","dateIssuedDisp":"2009-","dateIssuedKey":"2009","publisherPlace":"Basel"}],"part":{"year":"2019","issue":"11","volume":"11","text":"11(2019,11) Artikel-Nummer 1655, 17 Seiten","extent":"14"},"id":{"eki":["614095670"],"issn":["2072-6694"],"zdb":["2527080-1"]},"pubHistory":["1.2009 -"],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]}}],"recId":"1686331487","physDesc":[{"extent":"14 S."}],"id":{"eki":["1686331487"],"doi":["10.3390/cancers11111655"]},"name":{"displayForm":["Patrick Naumann, Jonathan Eberlein, Benjamin Farnia, Jakob Liermann, Thilo Hackert, Jürgen Debus and Stephanie E. Combs"]}} | ||
| SRT | |a NAUMANNPATCACHECTICB2620 | ||